Benzinga | Jul 7, 2021 09:07AM EDT

Ortho Clinical Diagnostics Announces Distribution Agreement With Thermo Fisher To Provide And Support MAS Quality Controls And LabLink xL Quality Assurance Software; Terms Not Disclosed

RARITAN, N.J., July 7, 2021 /CNW/ -- Ortho Clinical Diagnostics (NASDAQ:OCDX), one of the world's largest pure-play, in-vitro diagnostics (IVD) companies, today announced its distributionRARITAN, N.J., July 7, 2021 /CNW/ -- Ortho Clinical Diagnostics (NASDAQ:OCDX), one of the world's largest pure-play, in-vitro diagnostics (IVD) companies, today announced its distribution agreement with Thermo Fisher Scientific(tm) to provide and support MAS(tm) Quality Controls and LabLink xL(tm) Quality Assurance Software through Ortho's VITROS(r) QC Solutions to VITROS(r) System customers worldwide.*